The University of Chicago Header Logo

Connection

Tatjana Antic to Kidney Neoplasms

Back to Details
This is a "connection" page, showing publications Tatjana Antic has written about Kidney Neoplasms.
Tatjana Antic
Connection Strength
14.678
Kidney Neoplasms
  1. Comprehensive analysis of six MED15::TFE3 renal cell carcinomas including two novel solid MED15::TFE3 renal cell carcinomas, highlighting their morphologic, immunohistochemical and molecular differences from their cystic counterparts. Virchows Arch. 2026 Sep; 489(3):669-680.
    View in: PubMed
    Score: 0.643
  2. The Many Faces of TPM3::ALK Fusion Renal Cell Carcinoma: Case Report and Review of the Literature. Int J Surg Pathol. 2026 Aug; 34(5):1241-1246.
    View in: PubMed
    Score: 0.638
  3. Cytomorphologic and molecular characterization of metastatic renal cell carcinoma diagnosed by fine-needle biopsy: a single-institution study. J Am Soc Cytopathol. 2026 May-Jun; 15(3):197-206.
    View in: PubMed
    Score: 0.635
  4. Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. Histopathology. 2026 Apr; 88(5):1044-1050.
    View in: PubMed
    Score: 0.626
  5. MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors. Virchows Arch. 2026 Sep; 489(3):575-581.
    View in: PubMed
    Score: 0.623
  6. Renal Tumorigenesis via RAS/RAF/MAPK Pathway Alterations Beyond Papillary Renal Neoplasm With Reverse Polarity. Am J Surg Pathol. 2025 Dec 01; 49(12):1266-1278.
    View in: PubMed
    Score: 0.605
  7. Aggressive renal cell carcinoma with somatic BRCA2 mutation-an emerging entity? A case report with literature review. Virchows Arch. 2025 Aug; 487(2):471-476.
    View in: PubMed
    Score: 0.584
  8. GATA3 Expression in Solid Vimentin-Negative Eosinophilic Renal Epithelial Tumors-A Comprehensive Study of 48 Tumors. Int J Surg Pathol. 2025 Jun; 33(4):820-827.
    View in: PubMed
    Score: 0.580
  9. Oncocytoma-Like Angiomyolipoma of the Kidney: A Closer Look into the Clinicopathologic, Immunohistochemical, and Molecular Characteristics of a Rare Entity with Review of the Literature. Int J Surg Pathol. 2024 May; 32(3):625-631.
    View in: PubMed
    Score: 0.530
  10. Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature. Hum Pathol. 2023 06; 136:25-33.
    View in: PubMed
    Score: 0.518
  11. TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases. Hum Pathol. 2023 04; 134:124-133.
    View in: PubMed
    Score: 0.510
  12. The emerging role of NF2 alterations in new and established subtypes of renal cell carcinoma. Hum Pathol. 2023 03; 133:87-91.
    View in: PubMed
    Score: 0.490
  13. NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases. Am J Surg Pathol. 2022 05 01; 46(5):617-627.
    View in: PubMed
    Score: 0.487
  14. BAP1-Mutated Clear Cell Renal Cell Carcinoma. Am J Clin Pathol. 2021 04 26; 155(5):718-728.
    View in: PubMed
    Score: 0.454
  15. Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case. Pathology. 2021 Oct; 53(6):790-793.
    View in: PubMed
    Score: 0.446
  16. TSC/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+/CK20-/vimentin-: a validation study. Hum Pathol. 2021 09; 115:84-95.
    View in: PubMed
    Score: 0.443
  17. A Tale of 2 Morphologies: Diagnostic Pitfalls in TFEB-Associated Renal Cell Carcinomas, Including a Novel NEAT1-TFEB Fusion. Int J Surg Pathol. 2021 Feb; 29(1):21-29.
    View in: PubMed
    Score: 0.434
  18. Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous: Clinicopathologic and Molecular Study. Am J Surg Pathol. 2020 07; 44(7):943-954.
    View in: PubMed
    Score: 0.429
  19. Clinicopathologic Features of Small Renal Masses Associated With Distant Metastatic Disease. Am J Clin Pathol. 2020 04 15; 153(5):613-617.
    View in: PubMed
    Score: 0.422
  20. Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma. Am J Surg Pathol. 2019 08; 43(8):1135-1144.
    View in: PubMed
    Score: 0.402
  21. Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations? Am J Surg Pathol. 2018 07; 42(7):911-917.
    View in: PubMed
    Score: 0.373
  22. Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion. Am J Surg Pathol. 2017 Nov; 41(11):1576-1580.
    View in: PubMed
    Score: 0.356
  23. Primary epithelioid sarcoma of the kidney and adrenal gland: report of 2 cases with immunohistochemical and molecular cytogenetic studies. Hum Pathol. 2017 03; 61:158-163.
    View in: PubMed
    Score: 0.332
  24. Radical Nephrectomy for Renal Cell Carcinoma: ?Its Contemporary Role Related to Histologic Type, Tumor Size, and Nodal Status: A Retrospective Study. Am J Clin Pathol. 2016 Jun; 145(6):837-42.
    View in: PubMed
    Score: 0.320
  25. Partial nephrectomy for renal tumors: lack of correlation between margin status and local recurrence. Am J Clin Pathol. 2015 May; 143(5):645-51.
    View in: PubMed
    Score: 0.300
  26. Carbonic anhydrase IX (CAIX) does not differentiate between benign and malignant mesothelium. Am J Clin Pathol. 2014 Jul; 142(1):82-7.
    View in: PubMed
    Score: 0.283
  27. The expression of FOXL2 in pancreatic, hepatobiliary, and renal tumors with ovarian-type stroma. Hum Pathol. 2014 May; 45(5):1010-4.
    View in: PubMed
    Score: 0.274
  28. Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors. Hum Pathol. 2026 Sep; 175:106154.
    View in: PubMed
    Score: 0.161
  29. Percutaneous renal mass biopsies with no viable lesional cells - Recognizing different histologic patterns can help predict nondiagnostic vs. true negative biopsy and guide clinical management. Ann Diagn Pathol. 2026 Jun; 82:152607.
    View in: PubMed
    Score: 0.157
  30. Mixed epithelial and stromal tumor of the kidney and cystic nephroma share overlapping features: reappraisal of 15 lesions. Arch Pathol Lab Med. 2006 Jan; 130(1):80-5.
    View in: PubMed
    Score: 0.157
  31. Metastatic renal cell carcinoma with fibromyomatous stroma associated with tuberous sclerosis or MTOR, TSC1/TSC2-Mutations: A Series of 4 cases and a review of the literature. Hum Pathol. 2024 Nov; 153:105680.
    View in: PubMed
    Score: 0.145
  32. Cytopathology and clinicopathological correlation of renal neuroendocrine neoplasms. J Am Soc Cytopathol. 2024 Nov-Dec; 13(6):406-412.
    View in: PubMed
    Score: 0.141
  33. Actual encounters of the kidney kind: Exploring 48 cases of renal collision tumors through the lens of literature. Hum Pathol. 2024 03; 145:26-33.
    View in: PubMed
    Score: 0.138
  34. Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma. Histopathology. 2022 Nov; 81(5):577-586.
    View in: PubMed
    Score: 0.124
  35. Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): A single institution series. Urol Oncol. 2022 02; 40(2):18-24.
    View in: PubMed
    Score: 0.118
  36. Accuracy of Subclassification and Grading of Renal Tumors on Fine Needle Aspiration Cytology Alone. Acta Cytol. 2021; 65(2):140-149.
    View in: PubMed
    Score: 0.112
  37. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling. Hum Pathol. 2020 10; 104:18-29.
    View in: PubMed
    Score: 0.107
  38. Clinical Utility of Chromosome Genomic Array Testing for Unclassified and Advanced-Stage Renal Cell Carcinomas. Arch Pathol Lab Med. 2019 04; 143(4):494-504.
    View in: PubMed
    Score: 0.095
  39. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum. Virchows Arch. 2018 Jul; 473(1):85-93.
    View in: PubMed
    Score: 0.092
  40. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics. Hum Pathol. 2017 08; 66:152-158.
    View in: PubMed
    Score: 0.087
  41. Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia. Hum Pathol. 2014 Jul; 45(7):1406-13.
    View in: PubMed
    Score: 0.069
  42. Renal angiomyolipoma, fat-poor variant--a clinicopathologic mimicker of malignancy. Virchows Arch. 2013 Jul; 463(1):41-6.
    View in: PubMed
    Score: 0.066
  43. Primary benign vascular tumors and tumorlike lesions of the kidney: a clinicopathologic analysis of 15 cases. Virchows Arch. 2012 Dec; 461(6):669-76.
    View in: PubMed
    Score: 0.063
  44. A 26-year-old woman with weight loss and a renal mass. Urology. 2011 Nov; 78(5):994-7.
    View in: PubMed
    Score: 0.058
  45. Mediastinal epithelioid hemangioendothelioma metastatic to lymph nodes and pleural fluid: report of a case. Diagn Cytopathol. 2010 Feb; 38(2):113-6.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.